WALLSTREET-REVIEW ADJUSTS BIOTEC DIVIDEND RATIO TO 7.3 TO 1 SHARES 10 Q TO BE FILED BEFORE YEARS END

WALS adjusts BioTec shareholder distribution to 7.3:1 shares from prior calucation of 14:1 "E" to be removed from ticker before year's end

For Immediate Release

December 17, 2001, Lighthouse Point, Florida. Wallstreet-Review, Inc. OTCBB
(WALSE) a Florida corporation, today announced the new formula for WALS shareholders to receive shares in BioTec Energy Resources, Inc. (www.biotecsystems.com).

The new formula allows WALS shareholders to receive one share of BioTec for every 7.3 shares of WALS they own compared to the original amount of 14 to 1. The date of record to be eligible for the dividend is Jan 4, 2002.

WALS will have its third quarter 10Q filed before years end to remove the E" appended to its symbol. WALS anticipates filing its 10K by the end of January so it can proceed with its planned secondary offering in 2002.

WALS is a financial services company that assists emerging companies in moving from the private sector to the public markets.

Statements in this news release that are not descriptions of historical
facts are forward-looking statements that are subject to risks and uncertainties.
Words such as "expect," "intends," "believes," "plans," "anticipates" and
"likely" also identify forward-looking statements. All forward-looking
statements are based on current facts and analysis. Actual results may
differ materially from those currently anticipated due to a number of factors
including, but not limited to history of operating losses, anticipated
future losses, competition, future capital needs, the need for market acceptance,
dependence upon third parties, disruption of vital infrastructure and
intellectual property rights. All forward-looking statements are made
pursuant to the Securities Litigation Reform Act of 1995. Additional
information on factors that may affect the business and financial results of
the Company can be found in filings of the Company with the Securities and
Exchange Commission.

For further information contact: Jeff Daly at: 954-786-2020; Facsimile:
954-786-2080; or e-mail: jeff@wallstreet-review.net Additional information
is available at the Companys website: www.wallstreet-review.net